Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
58.74 USD | +0.48% | +4.91% | -14.29% |
01:28pm | Leerink Partners Starts Immunocore Holdings With Outperform Rating, $74 Price Target | MT |
Mar. 21 | Immunocore Holdings Files Mixed-Securities Shelf Registration | MT |
Sales 2024 * | 231M 290M | Sales 2025 * | 245M 308M | Capitalization | 2.37B 2.97B |
---|---|---|---|---|---|
Net income 2024 * | -71M -89.17M | Net income 2025 * | -89M -112M | EV / Sales 2024 * | 8.99 x |
Net cash position 2024 * | 293M 368M | Net cash position 2025 * | 219M 275M | EV / Sales 2025 * | 8.77 x |
P/E ratio 2024 * |
-37.6
x | P/E ratio 2025 * |
-26.7
x | Employees | 497 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 45.6% |
Latest transcript on Immunocore Holdings plc
1 day | +0.18% | ||
1 week | +4.91% | ||
Current month | -9.91% | ||
1 month | -6.96% | ||
3 months | -18.78% | ||
6 months | +33.76% | ||
Current year | -14.29% |
Managers | Title | Age | Since |
---|---|---|---|
Bahija Jallal
CEO | Chief Executive Officer | 62 | 18-12-31 |
Brian DiDonato
DFI | Director of Finance/CFO | 57 | 20-03-31 |
John Trainer
COO | Chief Operating Officer | 50 | 23-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Perez
BRD | Director/Board Member | 59 | 19-08-31 |
John Bell
CHM | Chairman | 71 | 15-02-28 |
Bahija Jallal
CEO | Chief Executive Officer | 62 | 18-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.23% | 1,026 M€ | +6.77% | - | |
0.18% | 0 M€ | 0.00% | - | |
0.14% | 5 M€ | +8.63% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 58.56 | +0.17% | 385 737 |
24-04-26 | 58.46 | +0.79% | 403,551 |
24-04-25 | 58 | -0.80% | 496,622 |
24-04-24 | 58.47 | +2.02% | 394,870 |
24-04-23 | 57.31 | +2.67% | 302,166 |
Delayed Quote Nasdaq, April 29, 2024 at 03:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.29% | 2.95B | |
+25.78% | 661B | |
+26.74% | 566B | |
-6.70% | 352B | |
+18.87% | 332B | |
+3.18% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.29% | 145B |
- Stock Market
- Equities
- IMCR Stock